ORIENT BIO Inc. (KRX: 002630)

ORIENT BIO Ratios and Metrics

Market cap in millions KRW. Fiscal year is April - March.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Nov 14, 2024	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Market Capitalization	55,134	187,317	58,433	107,869	176,914	194,884
Market Cap Growth	-3.55%	220.57%	-45.83%	-39.03%	-9.22%	-14.92%
Enterprise Value	146,781	190,173	60,013	198,892	236,940	251,125
Last Close Price	465.00	1580.00	574.00	1059.72	2347.29	2617.72
PS Ratio	0.93	3.60	1.57	3.55	6.90	1.79
PB Ratio	1.04	3.86	1.11	1.72	2.21	2.14
P/TBV Ratio	2.76	3.88	1.12	1.67	4.02	3.71
P/FCF Ratio	5.91	22.08	-	-	-	-
P/OCF Ratio	12.32	21.43	-	-	-	-
EV/Sales Ratio	2.48	3.66	1.61	6.55	9.25	2.30
EV/EBITDA Ratio	109.61	649.60	-	-	-	-
EV/FCF Ratio	15.73	22.42	-	-	-	-
Debt / Equity Ratio	0.20	0.17	0.18	0.13	0.80	0.57
Debt / EBITDA Ratio	7.96	27.69	-	-	-	-
Debt / FCF Ratio	1.14	0.96	-	-	-	-
Asset Turnover	0.72	0.71	0.47	0.22	0.14	0.64
Inventory Turnover	5.30	4.74	3.42	1.35	0.78	3.30
Quick Ratio	1.11	1.32	0.98	1.14	0.63	0.70
Current Ratio	1.80	1.91	1.75	2.17	1.06	1.36
Return on Equity (ROE)	-12.42%	-30.93%	-22.15%	-18.49%	-15.34%	-27.72%
Return on Assets (ROA)	-2.20%	-3.73%	-11.84%	-4.46%	-2.78%	-3.58%
Return on Capital (ROIC)	-2.75%	-4.63%	-14.24%	-5.69%	-3.45%	-4.18%
Earnings Yield	-12.43%	-8.35%	-20.53%	-18.08%	-7.84%	-10.05%
FCF Yield	16.92%	4.53%	-7.95%	-25.61%	-2.80%	-5.33%
Buyback Yield / Dilution	-8.36%	-9.70%	-32.48%	-8.49%	-2.09%	-10.20%
Total Shareholder Return	-8.36%	-9.70%	-32.48%	-8.49%	-2.09%	-10.20%

Source: S&P Capital IQ. Standard template. Financial Sources.